Epidemiological changes with potential implication for antifungal prescription recommendations for fungaemia: data from a nationwide fungaemia surveillance programme

Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America

Peter G. Pappas, Carol A. Kauffman, David R. Andes et al. · Clinical Infectious Diseases · 2009 · 3.2K citations · Full text

Pharmacy, Infectious Diseases, Microbiology +17

Delaying the Empiric Treatment of <i>Candida</i> Bloodstream Infection until Positive Blood Culture Results Are Obtained: a Potential Risk Factor for Hospital Mortality

Matthew R. Morrell, Victoria J. Fraser, Marin H. Kollef · Antimicrobial Agents and Chemotherapy · 2005 · 1.3K citations · Full text

Veterinary Medicine, Infectious Diseases, Microbiology +6

ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients

Oliver A. Cornely, Matteo Bassetti, Thierry Calandra et al. · Clinical Microbiology and Infection · 2012 · 1.2K citations · Full text

Life Sciences, Infectious Diseases, Microbiology +16

Time to Initiation of Fluconazole Therapy Impacts Mortality in Patients with Candidemia: A Multi‐Institutional Study

Kevin W. Garey, M Rege, Manjunath P. Pai et al. · Clinical Infectious Diseases · 2006 · 1.2K citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Impact of Treatment Strategy on Outcomes in Patients with Candidemia and Other Forms of Invasive Candidiasis: A Patient-Level Quantitative Review of Randomized Trials

David R. Andes, Nasia Safdar, John W. Baddley et al. · Clinical Infectious Diseases · 2012 · 796 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17